|
|||||
|
|
||||||
Journal of Clinical Oncology, Vol 23, No 30 (October 20), 2005: pp. 7467-7474 © 2005 American Society of Clinical Oncology. DOI: 10.1200/JCO.2005.01.7335 Ionizing Radiation and Tobacco Use Increases the Risk of a Subsequent Lung Carcinoma in Women With Breast Cancer: Case-Only DesignFrom the Department of Medical Epidemiology and Biostatistics, Karolinska Institutet; Department of Hospital Physics, Radiumhemmet, and Department of Medicine, Clinical Epidemiology Unit, Karolinska University Hospital; Department of Medical Radiation Physics, Stockholm University, Stockholm, Sweden; and Lombardi Cancer Center, Georgetown University Medical Center, Washington, DC. Address reprint requests to Michaela Prochazka, RN, MPH, Department of Epidemiology and Biostatistics, Karolinska Institutet, PO Box 281, SE-171 77, Stockholm, Sweden; e-mail: Michaela.Prochazka{at}meb.ki.se PURPOSE: To analyze the risk of lung cancer in women treated with radiotherapy for breast cancer. We accessed the lung dose in relation to different radiotherapy techniques, provided the excess relative risk (ERR) estimate for radiation-associated lung cancer, and evaluated the influence of tobacco use. PATIENTS AND METHODS: The Swedish Cancer Registry was used to identify 182 women diagnosed with breast and subsequent lung cancers in Stockholm County during 1958 to 2000. Radiotherapy was administered to 116 patients. Radiation dose was estimated from the original treatment charts, and information on smoking history was searched for in case records and among relatives. The risk of lung cancer was assessed in a case-only approach, where each woman contributed a pair of lungs.
RESULTS: The average mean lung dose to the ipsilateral lung was 17.2 Gy (range, 7.1 to 32.0 Gy). A significantly increased relative risk (RR) of a subsequent ipsilateral lung cancer was observed at CONCLUSION: Radiotherapy for breast cancer significantly increases the risk of lung carcinoma more than 10 years after exposure in women who smoked at time of breast cancer. Authors' disclosures of potential conflicts of interest are found at the end of this article.
This article has been cited by other articles:
|
||||||||||||
|
|||||||||||
|
Copyright © 2005 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
|